Article info
PDFOriginal research
Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
- Correspondence to Dr Koji Matsuo, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 90033, USA; koji.matsuo{at}gmail.com
Citation
Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
Publication history
- Received March 3, 2020
- Revision received April 9, 2020
- Accepted April 13, 2020
- First published May 5, 2020.
Online issue publication
October 29, 2020
Article Versions
- Previous version (5 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.